This is unpublished


he, him, his
Physician & Research Faculty
Professor, Division of Hematology and Oncology, University of Washington
Professor, Clinical Research Division, Fred Hutchinson Cancer Center
Sites of Practice
Fred Hutchinson Cancer Center - South Lake Union

Photo: Fred Hutch

Education, Training, Board Certifications 

  • M.D., Washington University School of Medicine 
  • Ph.D., Washington University School of Medicine
  • Residency, Barnes Jewish Hospital, Washington University School of Medicine 
  • Fellowship in Oncology, UW/Fred Hutch 
  • Medical Oncology, American Board of Internal Medicine 
  • Internal Medicine, American Board of Internal Medicine 

Clinical Expertise

  • Melanoma
  • Kidney Cancer



Research and/or clinical interests

Dr. Scott Tykodi specializes in translating immunotherapy advances from the laboratory into the clinic. He has led numerous clinical trials evaluating novel, immune-based therapeutics for patients with kidney cancer and other solid tumors. Dr. Tykodi is developing a new cellular immunotherapy for kidney cancer aimed at a marker called 5T4, which is found on the surface of almost all kidney cancer cells and only rarely on healthy adult cells.